These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 13721866)

  • 1. [Antagonistic action of cholinomimetic and central cholinolytics on the bioelectrical activity of the rabbit brain].
    DENISENKO PP
    Fiziol Zh SSSR Im I M Sechenova; 1961 Feb; 47():160-8. PubMed ID: 13721866
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of amizil, aprophen and their corresponding quinuclidine ethers on the bioelectrical activity of the brain].
    Mashkovskiĭ MD; Poshchina LF
    Farmakol Toksikol; 1967; 30(4):415-9. PubMed ID: 5598891
    [No Abstract]   [Full Text] [Related]  

  • 3. [The inhibition of pain reactions of the mouse by cholinomimetics and their antagonistic modification].
    Oelssner W; Andreas K
    Acta Biol Med Ger; 1969; 22(2):369-85. PubMed ID: 4391411
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological analysis of bioelectrical activity of the central nervous system of amphibia. I. The effect of some cholinergic and anticholinergic drugs on the frog's EEG.
    Kostowski W; Mészáros J
    Brain Res; 1967 Dec; 6(4):783-5. PubMed ID: 6080230
    [No Abstract]   [Full Text] [Related]  

  • 5. [Contribution to the study of central and peripheral cholinergics and cholinolytics. IV. Homologues of tremorine, oxotremorine and its methoiodide].
    Lévy J; Michel-Ber E; Denys A; Fumagalli N; Morland A
    Therapie; 1967; 22(3):671-88. PubMed ID: 6063445
    [No Abstract]   [Full Text] [Related]  

  • 6. Cholinolytic activity of centrophenoxine.
    Fusek J; Patocka J; Bajgar J
    Acta Biol Med Ger; 1972; 28(3):557-8. PubMed ID: 4403168
    [No Abstract]   [Full Text] [Related]  

  • 7. [Electroencephalographic analysis of the central action of phenacon].
    Toreva DK
    Farmakol Toksikol; 1968; 31(1):5-8. PubMed ID: 5675349
    [No Abstract]   [Full Text] [Related]  

  • 8. [On N-cholinolytics with predominantly central action].
    Golikov SN; Razumova MA; Selivanova AT
    Farmakol Toksikol; 1965; 28(1):20-3. PubMed ID: 5845034
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the relationship between central and peripheral cholinolytic effects of certain complex esters of diethylaminoethanol and aromatic acids].
    DENISENKO PP
    Biull Eksp Biol Med; 1961 Mar; 51():72-6. PubMed ID: 13721869
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of certain cholinolytics and cholinomimetics on hormonal induction of cholinesterase].
    Gevorkian ES; Panosian GA
    Zh Eksp Klin Med; 1974; 14(1):49-55. PubMed ID: 4432692
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical and electroencephalographic experiences with a new centrally-active anticholinergic drug (Bayer WH 4849)].
    FLUEGEL F; BENTE D
    Med Exp Int J Exp Med; 1961; 5():215-23. PubMed ID: 13893687
    [No Abstract]   [Full Text] [Related]  

  • 12. [Action of central cholinolytics and other neurotropic substances on neurogenic dystrophies].
    Anickov SV
    Clin Ter; 1965 Oct; 35(1):3-10. PubMed ID: 5860389
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical-electroencephalographic studies with "confusion"-inducing substances].
    FLUEGEL F; ITIL T
    Psychopharmacologia; 1962; 3():79-98. PubMed ID: 13893688
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimental acute edema; cerebral swelling and its prevention with central cholinolytics].
    DENISENKO PP
    Farmakol Toksikol; 1962; 25():269-76. PubMed ID: 13885439
    [No Abstract]   [Full Text] [Related]  

  • 15. An analysis of the activating system including its use for screening antiParkinson drugs.
    HIMWICH HE; RINALDI F
    Yale J Biol Med; 1955 Dec-1956 Feb; 28(3-4):308-19. PubMed ID: 13291855
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacology of central cholinolytics].
    DENISENKO PP
    Vestn Akad Med Nauk SSSR; 1960; 15(2)():20-30. PubMed ID: 13849578
    [No Abstract]   [Full Text] [Related]  

  • 17. [Contribution to the study of central and peripheral cholinergics and cholinolytics. 3. Ditran-oxotremorine antagonism].
    Denys A; Levy J; Michel-Ber E; Wierusz-Kowalska L
    Therapie; 1967; 22(2):383-96. PubMed ID: 6063426
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experimental bases for the use of central cholinolytics in practical medicine].
    DENISENKO PP
    Vestn Akad Med Nauk SSSR; 1962; 17(3)():48-58. PubMed ID: 13885440
    [No Abstract]   [Full Text] [Related]  

  • 19. [Analysis of "dissociation" between the effect of anticholinergic drugs on behavior and the electrical activity of the brain].
    Longo VG
    Actual Pharmacol (Paris); 1965; 18():289-309. PubMed ID: 5335793
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cholinergic mechanism of cortical activation].
    SMIRNOV GD; IL'IUCHENOK RIu
    Fiziol Zh SSSR Im I M Sechenova; 1962 Oct; 48():1141-5. PubMed ID: 13993080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.